Summary
Walmart Inc. has announced a proposed settlement agreement to resolve certain shareholder derivative actions concerning allegations of inadequate oversight in the distribution and dispensing of prescription opioids. The settlement, subject to court approval, would result in insurance carriers paying Walmart $123 million, minus any approved attorneys' fees and litigation expenses. Additionally, Walmart would commit to maintaining specific corporate governance practices for at least five years. This development aims to conclude ongoing legal disputes and avoid further costly litigation, though the company explicitly denies any admission of liability or wrongdoing.
Key Highlights
- 1Walmart has reached a settlement agreement to resolve shareholder derivative lawsuits related to opioid distribution and dispensing.
- 2The proposed settlement involves a payment of $123 million from insurance carriers to Walmart, subject to court approval and deduction of legal fees.
- 3As part of the settlement, Walmart will commit to maintaining certain corporate governance practices for a minimum of five years.
- 4The settlement does not involve any admission of liability or wrongdoing by Walmart or its directors and officers.
- 5The company previously established a Special Litigation Committee to investigate the claims and negotiate a resolution.
- 6The settlement is subject to approval by the Delaware Court of Chancery.
Frequently Asked Questions
This 8-K filing is primarily to disclose a proposed settlement agreement that Walmart Inc. has reached to resolve several shareholder derivative lawsuits concerning allegations of inadequate oversight in the distribution and dispensing of prescription opioids. It also serves to notify shareholders about the settlement process.
The financial impact is positive in that insurance carriers will pay Walmart $123 million. However, this amount will be reduced by any attorneys' fees and litigation expenses awarded by the court to the plaintiffs' counsel. Importantly, this settlement does not represent an admission of liability by Walmart.
Beyond the financial settlement from insurance carriers, Walmart has agreed to maintain specific corporate governance practices for at least five years. This aims to address the underlying concerns raised in the derivative lawsuits regarding oversight.
No, the company explicitly states that the settlement does not include any admission of liability, and the defendants expressly deny any wrongdoing. The settlement is a mechanism to resolve the litigation and its associated costs and risks.